Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä, Panagiotis A. Konstantinopoulos, Connor A. Jacobson et al.|Nature Communications|2020Cited by 342
Pre-Micro RNA Signatures Delineate Stages of Endothelial Cell Transformation in Kaposi SarcomaAndrea O’Hara, Dirk P. Dittmer, Pauline Chugh et al.|PLoS Pathogens|2009Cited by 70
Pathology of rituximab-induced Kaposi sarcoma flareLiron Pantanowitz, Bruce J. Dezube|BMC Clinical Pathology|2008Cited by 40
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä, Panagiotis A. Konstantinopoulos, D. Gulhan et al.|Nature Communications|2020Cited by 13
Abstract 4487: Association of the tumor-immune microenvironment with response to niraparib and pembrolizumab in relapsed, platinum-resistant ovarian cancerAnniina Färkkilä, Panagiotis A. Konstantinopoulos, Jia‐Ren Lin et al.|Immunology|2019Cited by 0